ConductScience.org, home

Paper32905214

Combination nivolumab and bevacizumab for metastatic myxofibrosarcoma: A case report and review of the literature.

Song L and 2 others. Mol Clin Oncol, 2020. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Combination nivolumab and bevacizumab for metastatic myxofibrosarcoma: A case report and review of the literature. Papers, record 32905214. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905214

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination nivolumab and bevacizumab for metastatic myxofibrosarcoma: A case report and review of the literature.
PubMed
Journal
Mol Clin Oncol
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.54
iCite
Revised in PubMed
2020-09-28
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Song LLei
2Pan DDejian
3Zhou RRengui

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128988646Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.Lancet Oncol2017https://conductscience.org/library/papers/28988646PubMed
229370992Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.Lancet Oncol2018https://conductscience.org/library/papers/29370992PubMed
330591101[First-line Combination Immunotherapy in Advanced Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi2018https://conductscience.org/library/papers/30591101PubMed
419451427
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043).
J Clin Oncol2009https://conductscience.org/library/papers/19451427PubMed
528440953Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.Cancer2017https://conductscience.org/library/papers/28440953PubMed
622595799Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.Lancet2012https://conductscience.org/library/papers/22595799PubMed
727087380[Chinese expert consensus on diagnosis and treatment of soft tissue sarcomas (Version 2015)].Zhonghua Zhong Liu Za Zhi2016https://conductscience.org/library/papers/27087380PubMed
826167500Immunotherapy for Bone and Soft Tissue Sarcomas.Biomed Res Int2015https://conductscience.org/library/papers/26167500PubMed
916192597Phase II study of doxorubicin and bevacizumab for patients with metastatic soft-tissue sarcomas.J Clin Oncol2005https://conductscience.org/library/papers/16192597PubMed
1015396Myxofibrosarcoma. A study of 30 cases.Acta Pathol Microbiol Scand A1977https://conductscience.org/library/papers/15396PubMed
1128042471Response to anti-PD1 therapy with nivolumab in metastatic sarcomas.Clin Sarcoma Res2016https://conductscience.org/library/papers/28042471PubMed
1228794805Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations.Ther Adv Med Oncol2017https://conductscience.org/library/papers/28794805PubMed
1330253794Response to PD1 inhibition in conventional chondrosarcoma.J Immunother Cancer2018https://conductscience.org/library/papers/30253794PubMed
1429895706Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma.Clin Cancer Res2018https://conductscience.org/library/papers/29895706PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
41718124Single-Cell RNA Sequencing Reveals the Cellular and Molecular Differences Between Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.Med Sci (Basel)2026https://conductscience.org/library/papers/41718124PubMed
38928713Giant Myxofibrosarcoma in the Lower Limb: An Overview of Diagnostic and Clinical Management.Diagnostics (Basel)2024https://conductscience.org/library/papers/38928713PubMed
37958307Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?Cancers (Basel)2023https://conductscience.org/library/papers/37958307PubMed
37835765Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives.Diagnostics (Basel)2023https://conductscience.org/library/papers/37835765PubMed
35782752Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives.Ther Adv Med Oncol2022https://conductscience.org/library/papers/35782752PubMed
34269922Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors.Curr Oncol Rep2021https://conductscience.org/library/papers/34269922PubMed
33594507[Subcutaneous nodule on the lower leg of an 87-year-old man].Hautarzt2021https://conductscience.org/library/papers/33594507PubMed
33562486Gemcitabine-Containing Chemotherapy for the Treatment of Metastatic Myxofibrosarcoma Refractory to Doxorubicin: A Case Series.Curr Oncol2021https://conductscience.org/library/papers/33562486PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32905214

GET https://conductscience.org/api/papers/v1/32905214/authors